Health
Synthetic nanobodies show potential for new COVID-19 therapies – The Science Board
Synthetic nanobodies may provide a practical avenue for the development of novel COVID-19 therapies compared to human antibodies, which are bulkier and require…
As there are currently no clinically validated vaccines and limited therapeutic treatments for SARS-CoV-2, developing new therapeutics is a worldwide endeavor, with neutralizing antibodies as a central component. However, traditional antibody production suffers from long development times and costly production.
As an alternative to human antibodies, nanobodies (single-domain antibodies) offer a promising approach, conferring the benefits of small size, increased stability, and superior simplicity…
Continue Reading